-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Elevance Health, Raises Price Target to $450

Benzinga·06/01/2026 14:20:11
Listen to the news
Truist Securities analyst David Macdonald maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $375 to $450.